References
Cesaro S, Chinello P, De Silvestro G et al (2003) Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases. Support Care Cancer 11:101–106
Grigull L, Beilken A, Schmid H et al (2006) Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Support Care Cancer 14:783–786
Grigull L, Pulver N, Goudeva L et al (2006) G-CSF mobilized granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Support Care Cancer 14:910–916
Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O’Brien S, Freireich EJ (1995) Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 10:188–193
Kontoyiannis DP, Bodey GP, Hanna H et al (2004) Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma 45:139–141
Peters C, Minkov M, Matthes-Martin S et al (1999) Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised patients. Br J Haematol 196:689–696
Raad II, Hachem RY, Herbrecht R et al (2006) Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 42:1398–1403
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cesaro, S., Marson, P. Does granulocyte transfusion play a role in the multidisciplinary treatment of invasive mycosis?. Support Care Cancer 15, 233–234 (2007). https://doi.org/10.1007/s00520-006-0151-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-006-0151-5